相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA
Marleen J. A. Koel-Simmelink et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis
Sara Llufriu et al.
JAMA NEUROLOGY (2014)
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
J. Kuhle et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Charlotte Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Role of Phosphorylated Neurofilament H as a diagnostic and prognostic marker in traumatic brain injury
Moh Omar Ghonemi et al.
EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE (2013)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Neurofilament ELISA validation
Axel Petzold et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
E. C. Tallantyre et al.
BRAIN (2009)
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
X. Montalban et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry
Bas Jasperse et al.
JOURNAL OF NEUROLOGY (2007)
The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers
A Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
A Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy
MJ Eikelenboom et al.
NEUROLOGY (2003)
分享论文
